Abbott to collaborate with Janssen and Pharmacyclics
21 February 2013 | By Abbott
Abbott will collaborate with Janssen Biotech and Pharmacyclics to explore the benefits of Abbott's proprietary FISH technology...
List view / Grid view
News
Announcement of application for approval in Japan of DPT-IPV vaccine
20 February 2013 | By Daiichi Sankyo
DPT-IPV vaccine for prevention of Diphtheria, Pertussis, Tetanus, and acute Poliomyelitis...
Phase 3 data shows bendamustine plus rituximab doubles progression-free survival in patients with iNHL and MCL compared with CHOP-R
Results from the StiL NHL-1 study...
Merck and Samsung Bioepis enter biosimilars development and commercialization agreement
20 February 2013 | By Merck
Merck and Samsung Bioepis Co., Ltd., entered into an agreement...
Gilead and Teva reach settlement agreement in Viread ® patent litigation
19 February 2013 | By Gilead Sciences
Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation...
Shire’s VPRIV® wins first ever “Novel Treatment Award”
19 February 2013 | By Edelman on behalf of Shire
"Shire has demonstrated its commitment to developing new therapies for the treatment of rare genetic diseases..."
Gilead’s sofosbuvir for hepatitis C meets primary endpoint in fourth pivotal Phase 3 study
19 February 2013 | By Gilead Sciences
Topline results from the Phase 3 FUSION study...
Sanofi New Drug Application for Lixisenatide accepted for review by FDA
19 February 2013 | By Sanofi
Sanofi announced that the U.S. FDA has accepted for review a New Drug Application for lixisenatide...
GSK and Theravance announce FDA acceptance of NDA submission in the US for ANORO ELLIPTATM for COPD
19 February 2013 | By GlaxoSmithKline
The NDA for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI has been accepted...
Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients
15 February 2013 | By Novartis
The FDA has approved Zortress®...
ViiV Healthcare announces FDA priority review designation for dolutegravir as a potential treatment for HIV infection
15 February 2013 | By GlaxoSmithKline
The FDA has granted a priority review designation to dolutegravir...
Novo Nordisk launches NovoSeven® with pre-filled syringe for fast bleeding control
14 February 2013 | By Novo Nordisk
Novo Nordisk announced that NovoSeven® is now available...
Metrohm and FOSS enter strategic alliance
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors.
Daiichi Sankyo announces development of nucleic acid treatment for DMD utilizing proprietary technology
14 February 2013 | By Daiichi Sankyo
Daiichi Sankyo will establish a new company, Orphan Disease Treatment Institute Co., Ltd...
Bristol-Myers Squibb Appoints Ann Powell Judge Senior Vice President, Human Resources
14 February 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced that Ann Powell Judge will join the company...
